Table 1.
Sample Demographic Characteristics
| Breast Cancer (n=113) | Healthy Control (n=37) | |
|---|---|---|
| Age at baseline (years) | 62.7 (3.9) | 62.5 (5.2) |
| Estimated premorbid IQ (WRAT-4 SS) | 112.5 (15.3) | 118.6 (18.6) |
| Handedness | ||
| Right | 99 | 33 |
| Left or ambidexterous | 14 | 4 |
| Cancer stage | ||
| I | 65 | |
| III | 37 | |
| IV | 9 | |
| Endocrine Therapy | ||
| Tamoxifen | 12 | |
| Arimidex | 64 | |
| Aromasin | 18 | |
| Femara | 19 | |
| Surgery | 113 | |
| Mastectomy | 36 | |
| Lumpectomy | 85 | |
| Sentinel node biopsy | 101 | |
| Axillary node biopsy | 40 | |
| Time since surgery | 4.2 (1.2) | |
| Received radiotherapy | 88 | |
| Years since radiotherapy | 3.8 (1.3) | |
| Received chemotherapy | 59 | |
| AC-T | 38 | |
| CMF | 14 | |
| EC-T | 3 | |
| FEC | 1 | |
| CAF | 2 | |
| Taxol | 1 | |
| Years since chemotherapy | 4.2 (1.1) | |
| STAI Anxiety | 32.4 (8.6) | 33.1 (1.4) |
| CESD Depression | 8.6 (8.2) | 7.8 (6.5) |
| FACT-COG | ||
| Memory | 20.4 (5.9) | 23.5 (3.2) |
| Verbal | 18.5 (4.8) | 19.2 (3.6) |
| Concentration | 12.4 (3.2) | 13.6 (2.4) |
| Mental Acuity | 12 (3.4) | 13.4 (2) |
| PCI | 56.5 (12.7) | 59.4 (8.3) |
| QOL Impact | 13.7 (3) | 14.3 (2.4) |
| PCA | 19.5 (6.3) | 22.7 (4.5) |